Association of Hypometilating Agents (HMA) plus Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Latagliata, R;Cristiano, G;Lama, D;Fenu, S;Rizzo, L;Cambò, B;Zoletto, S;Spirito, F;Cavalca, F;Cattaneo, D;Cenfra, N;De Luca, G;Vangone, BE;Di Veroli, A;Palmieri, R;Annunziata, M;Mulas, O;Abruzzese, E;Molteni, A;Piedimonte, M;Carmosino, I;Salutari, P;Biagi, A;Bocchia, M;Santopietro, M;Binotto, G;Iurlo, A;Crugnola, M;Riva, M;Piccioni, AL;Elli, EM;Curti, A;Poloni, A

2022-01-01